Expanding nursing knowledge for therapeutic plasma exchange a literature review paper

2017 ◽  
Vol 56 (5) ◽  
pp. 774-777 ◽  
Author(s):  
Susan Main
2021 ◽  
Vol 12 ◽  
Author(s):  
Tina S. Ipe ◽  
Adeola R. Davis ◽  
Jay S. Raval

Background: Patients with Myasthenia Gravis (MG) can be treated acutely with therapeutic plasma exchange (TPE) or intravenous immune globulin (IVIG). To date, there is no definitive understanding of which of the two treatments is more effective and safer. The purpose of this study was to systematically review the literature on the comparative efficacy and safety of TPE to other available treatments for MG.Methods: A systematic literature search for studies published between 1997 and 2017 was performed per Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines using two database sources, MEDLINE (through the PubMed database) and Cochrane Library.Results: The search strategy resulted in 535 articles whose abstracts were reviewed. Among these, 165 full texts articles were reviewed for eligibility and 101 articles were excluded. Of the 165 articles, 64 articles were included for a systematic literature and 11 articles for a meta-analysis.Conclusions: This systematic literature review and meta-analysis of treatment options showed that there was a higher response rate with TPE than IVIG in acute MG patients and patients undergoing thymectomy. There was no difference in mortality between the two treatment options. Our findings highlight the need for additional randomized clinical trials in these patients with MG.


2021 ◽  
Vol 40 ◽  
Author(s):  
Ajay Kumar ◽  
Anand Sharma ◽  
Yatendra Mohan ◽  
Itish Patnaik ◽  
Ashok Kumar ◽  
...  

Transfusion ◽  
2016 ◽  
Vol 56 (9) ◽  
pp. 2368-2373 ◽  
Author(s):  
Michelle L. Grant ◽  
Julie K. Karp ◽  
Michele Palladino ◽  
Nguyet Le ◽  
Nancy Hall ◽  
...  

2020 ◽  
Vol 16 ◽  
Author(s):  
Milad Modarresi ◽  
Ahmed Amro ◽  
Mohammad Amro ◽  
Amal Sobeih ◽  
Uzo Okoro ◽  
...  

Background: A grave complication of thyrotoxicosis, or thyroid storm, is the development of heart failure and cardiomyopathy. Recognizing this condition is imperative in preventing further left ventricular dysfunction and cardiogenic shock. This manuscript aims to review the literature on cardiogenic shock associated with thyrotoxicosis and present management recommendations on this rare condition. Method: A literature search was performed in December of 2018, using the PubMed medical search engine. A systematic search was carried out using the keywords Thyroid Storm AND Cardiogenic Shock and Thyrotoxicosis AND Shock. Management: A) Decrease of thyroid hormone levels using therapeutic plasma exchange B) LV Unloading and ventilation by Impella and Extracorporeal Mechanical Ventilation (ECMO). Conclusion: Patients presenting with thyroid storm-induced shock may not be suitable candidates for traditional management with β-adrenergic blockers (β-blockers). Use of β-blockers could exasperate their condition. Through extensive literature review on this rare condition, the most effective management was found to be therapeutic plasma exchange in order to decrease thyroid hormone levels, which have direct toxic effect on the heart. Furthermore, the use of ECMO and Impella are advised to reduce pressure on the heart and ensure the patient’s organs are well oxygenated and perfused while the left ventricle is recovering.


Author(s):  
M. Wind ◽  
A.G.A. Gaasbeek ◽  
L.E.M. Oosten ◽  
T.J. Rabelink ◽  
J.M.M. van Lith ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document